Dithranol in an Emulsifying Oil Base (Bio-Wash-Oil) for the Treatment of Psoriasis of the Scalp

Skin Pharmacology and Physiology

Volumn 17, Issue 2, 2004, Pages 91-97

  Wulff Woesten, A ^a   Ohlendorf, D ^a   Henz, B M ^a   Haas, N ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Anthralin; Day care clinic; Detergent; Hydrophilic formulation; Micanol ; Psoriasis Area and Severity Index score

Indexed keywords

DITHRANOL;

ADULT; AGED; ARTICLE; BURNING SENSATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; DRY SKIN; EMULSION; FEMALE; HUMAN; HYDROPHILICITY; KERATOCONJUNCTIVITIS; LIPOPHILICITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; PAIN; PRIORITY JOURNAL; PSORIASIS; SIDE EFFECT; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTHRALIN; DRUG THERAPY, COMBINATION; EMULSIONS; FEMALE; GLYCERIDES; HUMANS; MALE; MIDDLE AGED; OILS; OINTMENTS; PSORIASIS; SCALP; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 1342280465     PISSN: 16605527     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076019     Document Type: Article

References (23)

1. van de Kerkhof PC, de Hoop D, de Korte J, Kuipers MV: Scalp psoriasis, clinical presentations and therapeutic management. Dermatology 1998;197:326-334.
2. van de Kerkhof PC, Steegers Theunissen RP, Kuipers MV: Evaluation of topical drug treatment in psoriasis. Dermatology 1998;197:31-36.
3. Larko O: Problem sites: scalp, palm and sole, and nail. Dermatol Clin 1995;13:771-777.
4. Green C, Ganpule M, Harris D, Kavanagh G, Kennedy C, Mallett R, Rustin M, Downes N: Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp. Br J Dermatol 1994;130:483-487.
5. Lebwohl M: Anthralin. Dermatologic Therapy 1999;11:8-13.
6. Hindson C: Treatment of psoriasis of the scalp. An open assessment of 0.1% dithranol in a 17% urea base (Psoradrate). Clinical trials journal 1980;17:131.
7. Wright S, Mann RJ: Comparison of a cream containing 0.1% dithranol in a 17% urea base (Psoradrate) with coal tar pomade in the treatment of scalp psoriasis. Clin Exp Dermatol 1985;10:375-378.
8. Kammerau B, Zesch A, Schaefer H: Absolute concentrations of dithranol and triacetyl-dithranol in the skin layers after local treatment: in vivo investigations with four different types of pharmaceutical vehicles. J Invest Dermatol 1975;64:145-149.
9. Wang JC, Patel BG, Ehmann CW, Lowe N: The release and percutaneous permeation of anthralin products, using clinically involved and uninvolved psoriatic skin. J Am Acad Dermatol 1987;16:812-821.
10. Meffert H, Muller G, Sönnichsen N: Dithranol therapy of common psoriasis of the scalp. Dermatol Monatsschr 1979;165:224-225.
11. Van der Vleuten CJ, Gerritsen MJ, De Jong EM, Elbers M, De Jongh GJ, van de Kerkhof PC: A novel dithranol formulation (Micanol): the effects of monotherapy and UVB combination therapy on epidermal differentiation, proliferation and cutaneous inflammation in psoriasis vulgaris. Acta Derm Venereol 1996;76:387-391.
12. Klaber MR, Hutchinson PE, Pedvis Leftick A, Kragballe K, Reunala TL, Van de Kerkhof PC, Johnsson MK, Molin L, Corbett MS, Downess N: Comparative effects of calcipotriol solution (50 micrograms/ml) and betamethasone 17-valerate solution (1 mg/ml) in the treatment of scalp psoriasis. Br J Dermatol 1994;131:678-683.
13. Walker GB, Harrison PV, Seville RH, Smith JF: Short contact dithranol therapy: advantages of a stiff emulsifying ointment base. Br J Dermatol 1989;120:277-283.
14. Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS, et al: A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. J Am Acad Dermatol 1991;24:443-447.
15. Franz TJ, Parsell DA, Halualani RM, Hannigan JF, Kalbach JP, Harkonen WS: Betamethasone valerate foam 0.12%: a novel vehicle with enhanced delivery and efficacy. Int J Dermatol 1999;38:628-632.
16. Feldman SR, Sangha N, Setaluri V: Topical corticosteroid in foam vehicle offers comparable coverage compared with traditional vehicles. J Am Acad Dermatol 2000;42:1017-1020.
17. Swinehart JM, Barkoff JR, Dvorkin D, Fisher G, Peets E: Mometasone furoate lotion once daily versus triamcinolone acetonide lotion twice daily in psoriasis. Int J Dermatol 1989;28:680-681.
18. Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, Nieboer C, Roed Petersen J, Strand A, Tikjob G: Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991;337:193-196.
19. Lassus A, Lauharanta J, Kanerva L, Juvakoski T: Treatment of scalp psoriasis. A new dexamethasone preparation in a double-blind trial with hydrocortison-butyrate. Schweiz Rundsch Med Prax 1985;74:382-383.
20. Lassus A: Local treatment of psoriasis of the scalp with clobetasol propionate in alcoholic solution: a comparison of once and twice a day application. Curr Med Res Opin 1976;4:214-217.
21. Roduner J, Krebs A: Dermovate scalp application in dermatology. A multi-centre Swiss study. Ther Umsch 1980;37:589-594.
22. Shemer A, Nathansohn N, Kaplan B, Weiss G, Newman N, Trau H: Treatment of scalp seborrheic dermatitis and psoriasis with an ointment of 40% urea and 1% bifonazole. Int J Dermatol 2000;39:532-534.
23. Katz HI, Lindholm JS, Weiss JS, Shavin JS, Morman M, Bressinck R, Cornell R, Pariser DM, Pariser RJ, Weng W, et al: Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Clin Ther 1995;17:390-401.